LALANI Rx Consulting, Inc.

1 FDA products 1 active ingredients HUMAN OTC DRUG

LALANI Rx Consulting, Inc. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human otc drug products.

About LALANI Rx Consulting, Inc.

LALANI Rx Consulting, Inc. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE. Most of these labels are human otc drug products. Labelling across this portfolio most often references: temporary relief, pain temporarily, shrinks hemorrhoidal, anorectal discomfort. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — TOPICAL 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from LALANI Rx Consulting, Inc.

Brand nameGenericTypeRoute
SECONDARY NUMB Lidocaine Phenylephrine Gel LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE HUMAN OTC DRUG TOPICAL

Frequently asked questions

How many FDA drug products does LALANI Rx Consulting, Inc. make?
1 FDA drug label records name LALANI Rx Consulting, Inc. as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does LALANI Rx Consulting, Inc. produce?
The most frequent active ingredients in this portfolio are LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE.

Are LALANI Rx Consulting, Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human otc drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.